Associate Professor (Cancer Science Institute)

National University of Singapore; Singapore; On-site; SGD 80,000 - 100,000; Full time

Job summary

A leading research institution in Singapore seeks an Associate Professor for the Cancer Science Institute. Candidates should have a Ph.D. and a proven track record in cancer research, including publications and funding success. This position offers access to world-class research facilities, competitive packages, and opportunities for interdisciplinary collaborations. Ideal for visionary scientists looking to make significant contributions to cancer biology.

Benefits

Competitive start-up packages

Institutional research funding

Globally benchmarked salary and benefits

Qualifications

• Ph.D. and/or M.D. in a relevant field.
• Strong track record of research excellence.
• Distinguished portfolio of publications in cancer research.
• Success in securing competitive research funding.

Responsibilities

• Shape new research directions in cancer science.
• Lead multidisciplinary research initiatives.
• Collaborate with international academic and industry partners.

Skills

Research excellence

Grant writing

Interdisciplinary collaboration

Education

Ph.D. and/or M.D. in a relevant field

Job description

Job Title: Associate Professor (Cancer Science Institute)

Posting Start Date: 02/02/2026

Job Description

The Cancer Science Institute of Singapore (CSI) at the National University of Singapore (NUS) invites applications for multiple tenure-track and tenured faculty positions at the Assistant, Associate, or Full Professor level.

CSI is a globally recognized research institute committed to advancing the frontiers of cancer biology, immunology, and translational medicine. With a mission to transform cancer detection, treatment, and prevention, our purpose-built institute leverages state-of-the-art infrastructure, multidisciplinary expertise, and strong clinical partnerships to deliver impactful, patient-centered research. Our scientific community spans biological, computational, and engineering disciplines, focusing on the unique cancer challenges of Asia while contributing meaningfully to global cancer research.

We are seeking exceptional, visionary scientists to join our expanding faculty and shape new research directions that complement our existing strengths. Candidates from all areas of cancer research are welcome, with particular interest in the following domains:

• Computational Biology of Cancer Evolution
• Cancer Immunology and Immunotherapy
• Epithelial Cancer Biology

We welcome applications from scientists who meet the following criteria:

• A Ph.D. and/or M.D. in a relevant field
• A strong track record of research excellence, commensurate with career stage
• A distinguished portfolio of publications, research leadership, and scientific contributions in cancer research
• Demonstrated success in securing competitive research funding and leading multidisciplinary research initiatives

Successful candidates will join a vibrant and collaborative research environment with access to:

• World-class laboratory facilities and advanced core technologies
• Competitive start-up packages and institutional research funding
• A globally benchmarked salary and benefits package
• Extensive opportunities for interdisciplinary collaborations across NUS and with international academic and industry partners

Application Documents

To apply, please submit the following documents:

• Cover Letter
  • Describe your background, research interests, and how your work aligns with CSI’s mission and strategic priorities.
• Comprehensive Curriculum Vitae
  • Include a complete list of publications, grants awarded, honors, and leadership roles.
• Statement of Key Achievements and Future Research Plans (up to 1500 words)
  • Highlight your most significant contributions to cancer research.
  • Articulate your future research vision and potential synergies with CSI.
• Three References
  • Provide contact details of three senior scientists who can speak to your qualifications and research impact.